Integrase fusion proteins and their use with integrating gene therapy
Details for Australian Patent Application No. 2005205226 (hide)
International Classifications
Event Publications
20 July 2006 PCT application entered the National Phase
PCT publication WO2005/068641 Priority application(s): WO2005/068641
18 November 2010 Application Accepted
Published as AU-B-2005205226
17 March 2011 Standard Patent Sealed
9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005205229-Process for the production of asymmetric transformation catalysts
2005205224-Metallocene-based chiral phosphine or arsine ligands
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser